Contact Us
Drug Search Results
More Filters [+]

Tarenflurbil

Alternative Names: tarenflurbil, r-flurbiprofen, mpc-7869, TMP-001, TMP001, TMP 001
Latest Update: 2023-06-15
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: JNK Activator

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: Oral,Topical

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Myrexis
Company Location: NEW YORK NY 10020
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Tarenflurbil

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Alzheimer Disease

Phase 2: Dermatitis, Atopic|Prostate Cancer|Multiple Sclerosis, Relapsing-Remitting|Skin Cancer|Melanoma

Phase 1: Healthy Volunteers

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
2014-004483-38

P2

Completed

Multiple Sclerosis, Relapsing-Remitting

2018-04-20

TMP001_MS

P2

Completed

Multiple Sclerosis, Relapsing-Remitting

2018-04-01

FLIP0112

P1

Completed

Healthy Volunteers

2014-09-01

2011-002571-42

P2

Completed

Dermatitis, Atopic

2012-04-19

Recent News Events

Date

Type

Title

06/15/2023

PubMed

 Topological effects in ultrafast photoinduced processes between flurbiprofen and tryptophan in linked dyads and within human serum albumin.

04/01/2023

PubMed

 Comparison of in vivo pharmacokinetic behaviors of R- and S-flurbiprofen after intravenous injection of flurbiprofen axetil.

06/01/2022

PubMed

 Comparison of percutaneous permeation profiles of flurbiprofen enantiomers.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions